PMID- 34950365 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220429 IS - 1941-6911 (Print) IS - 1941-6911 (Electronic) IS - 1941-6911 (Linking) VI - 14 IP - 1 DP - 2021 Jun-Jul TI - Active Implantable cardioverter-defibrillators in Continuous-flow Left Ventricular Assist Device Recipients. PG - 20200490 LID - 10.4022/jafib.20200490 [doi] LID - 20200490 AB - INTRODUCTION: Implantable cardioverter-defibrillator (ICD) in patients with heart failure with reduced ejection fraction reduces mortality secondary to malignant arrhythmias. Whether end-stage heart failure (HF) with continuous-flow left ventricular assist device (cf-LVAD) derive similar benefits remains controversial. METHODS: We performed a systematic literature review and meta-analysis of all published studies that examined the association between active ICDs and survival in advanced HF patients with cfLVAD. We searched PubMed, Medline, Embase, Ovid, and Cochrane for studies reporting the association between ICD and all-cause mortality in advanced HF patients with cfLVAD. Mantel-Haenszel risk ratio (RR) random-effects model was used to summarize data. RESULTS: Ten studies (9 retrospective and one prospective) with a total of 7,091 patients met inclusion criteria. There was no difference in all-cause mortality (RR 0.84, 95% CI 0.65-1.10, p=0.20, I(2) =62.40%), likelihood of survival to transplant (RR 1.07, 95% CI 0.98-1.17, p= 0.13, I(2) =0%), RV failure (RR 0.74, 95% CI 0.44-1.25, p = 0.26, I(2) =34%) between Active ICD and inactive/no ICD groups, respectively. Additionally, 27.5% received appropriate ICD shocks, while 9.5% received inappropriate ICD shocks. No significant difference was observed in terms of any complications between the two groups. CONCLUSIONS: All-cause mortality, the likelihood of survival to transplant, and worsening RV failure were not significantly different between active ICD and inactive/no ICD in cf-LVAD recipients. A substantial number of patients received appropriate ICD shocks suggesting a high-arrhythmia burden. The risks and benefits of ICDs must be carefully considered in patients with cf-LVAD. FAU - Shah, Kuldeep AU - Shah K AD - Division of Cardiology, Cardiac Arrhythmia Service, Beaumont Hospital, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan. FAU - Chaudhary, Rahul AU - Chaudhary R AD - Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, PA. FAU - K Turagam, Mohit AU - K Turagam M AD - Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, NY. FAU - Shah, Mahek AU - Shah M AD - Division of Cardiology, Thomas Jefferson University Hospital, Philadelphia, PA. FAU - Patel, Brijesh AU - Patel B AD - Division of Cardiology, West Virginia University Medical Center, Morgantown, VW. FAU - Lanier, Gregg AU - Lanier G AD - Division of Cardiology, Westchester Medical Center, New York Medical College, Valhalla, NY. FAU - Lakkireddy, Dhanunjaya AU - Lakkireddy D AD - Cardiac Arrhythmia Service, Kansas City Heart Rhythm Institute and Research Foundation, Kansas City, KS. AD - DL and JG are co-senior authors. FAU - Garg, Jalaj AU - Garg J AD - Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, CA. AD - DL and JG are co-senior authors. LA - eng PT - Journal Article DEP - 20210630 PL - United States TA - J Atr Fibrillation JT - Journal of atrial fibrillation JID - 101514767 PMC - PMC8691323 OTO - NOTNLM OT - Continuous-flow LVAD OT - Implantable cardioverter-defibrillator OT - Mortality EDAT- 2021/12/25 06:00 MHDA- 2021/12/25 06:01 PMCR- 2021/06/30 CRDT- 2021/12/24 05:49 PHST- 2021/03/26 00:00 [received] PHST- 2021/04/20 00:00 [revised] PHST- 2021/06/26 00:00 [accepted] PHST- 2021/12/24 05:49 [entrez] PHST- 2021/12/25 06:00 [pubmed] PHST- 2021/12/25 06:01 [medline] PHST- 2021/06/30 00:00 [pmc-release] AID - 10.4022/jafib.20200490 [doi] PST - epublish SO - J Atr Fibrillation. 2021 Jun 30;14(1):20200490. doi: 10.4022/jafib.20200490. eCollection 2021 Jun-Jul.